Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma

Journal of Pharmacological Sciences

Volumn 106, Issue 3, 2008, Pages 444-451

  Chang, Ki Lee ^a,b   Seung, Hwa Son ^a,b   Kwang, Kyun Park ^a,b   Park, Jung Han Yoon ^c   Soon, Sung Lim ^c   Won, Yoon Chung ^a,b  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Anticancer activity; Cisplatin; Hepatotoxicity; Isoliquiritigenin; Nephrotoxicity

Indexed keywords

CISPLATIN; CREATININE; GLUTATHIONE; ISOLIQUIRITIGENIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RENAL PROTECTION; REPEATED DRUG DOSE; TUMOR VOLUME; TUMOR XENOGRAFT; UREA NITROGEN BLOOD LEVEL;

EID: 41549142696     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071498     Document Type: Article

References (43)

1. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res. 2006;66:3347-3350.
2. Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985;55:2303-2316.
3. Winston JA, Safirstein R. Reduced renal flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985;249:F490-F496.
4. Chirino YI, Hernandez-Pando R, Pedraza-Chaveri J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol. 2004;4:20-29.
5. Jones TW, Chopra S, Kaufman JS, Flamenbaum W, Trump BF. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Lab Invest. 1985;52:363-374.
6. Pollera CF, Meglio F, Nardi M, Vitelli G, Morolla P. Cisplatin induced hepatic toxicity. J Clin Oncol. 1987;5:318-319.
7. Weijl NI, Cleton FJ, Osanto S. Free radical and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev. 1997;23:209-240.
8. Mora Lde O, Antunes LM, Francescato HD, Bianchi Mde L. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2003;47:517-522.
9. Stewart DJ, Benjamin RS, Luna M. Human tissue distribution of platinum after cis-diaminedi-chloroplatinum. Cancer Chemother Pharmacol. 1982;10:51-54.
10. 2+ in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol. Appl Pharmacol. 1997;146:261-269.
11. Anand AJ, Bashey B. Newer insights into cisplatin nephro toxicity. Ann Pharmacother. 1993;27:1519-1525.
12. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004;195:221-230.
13. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomized, double-blind, placebo-controlled study. Eur J Cancer. 2004;40:1713-1723.
14. Yu SM, Kuo SC. Vasorelaxant effect of Isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Br J Pharmacol. 1995;114:1587-1594.
15. Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, et al. Anti-platelet action of Isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol. 1992;212:87-92.
16. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflate. Bioorg Med Chem. 1998;6:339-347.
17. Iwashita K, Kobori M, Yamaki K, Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem. 2000;64:1813-1820.
18. Ma J, Fu NY, Pang DB, Wu WY, Xu AL. Apoptosis induced by Isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med. 2001;67:754-757.
19. Maggiolini M, Statti G, Vivacqua A, Gabriele S, Rago V, Loizzo M, et al. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol. 2002;82:315-322.
20. Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, et al. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett. 2002;183:23-30.
21. Ii T, Satomi Y, Katoh D, Shimada J, Baba M, Okuyama T, et al. Induction of cell cycle arrest and p21 (CIP1/WAF1) expression in human lung cancer cells by Isoliquiritigenin. Cancer Lett. 2004;207:27-35.
22. Hsu YL, Kuo PL, Lin CC. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci. 2005;77:279-292.
23. Jung JI, Lim SS, Choi HJ, Cho HJ, Shin HK, Kim EJ, et al. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem. 2006;17:689-696.
24. Yamamoto S, Aizu E, Jiang H, Nakadate T, Kiyoto I, Wang JC, et al. The potent anti-tumor-promoting agent Isoliquiritigenin. Carcinogenesis. 1991;2:317-323.
25. Baba M, Asano R, Takigami I, Takahashi T, Ohmura M, Okada Y, et al. Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of Isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull. 2002;25:247-250.
26. 2 and nitric oxide, causes apoptosis, and suppress aberrant crypt foci development. Cancer Sci. 2004;95:448-453.
27. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990;36:1440-1443.
28. Ohkawa N, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
29. Higach T. Critical review on the determination of glutathione in biological preparation. Proteins Nucleic Acid Enzyme. 1988;33:1370.
30. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999;31:971-997.
31. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med. 2003;142:178-186.
32. Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem. 1998;178:127-133.
33. Fujieda M, Naruse K, Hamauzu T, Miyazaki E, Hayashi Y, Enomoto R, et al. Effect of selenium on Cisplatin-induced nephrotoxicity in rats. Nephron Exp Nephrol. 2006;104:e112-e122.
34. Ajith TA, Usha S, Nivitha V. Ascorbic acid and α-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta. 2007;375:82-86.
35. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull. 2005;28:1635-1638.
36. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, et al. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct. 2006;24:357-361.
37. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62:3868-3875.
38. Sasada T, Iwata S, Sato N, Kitaoka Y, Hirota K, Nakamura K, et al. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest. 1996;97:2268-2276.
39. Miyajima A, Nakashima J, Yoshioka K, Tachibana M, Tazaki H, Murai M. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer. 1997;76:206-210.
40. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals. 1996;9:139-142.
41. Kuhad A, Tirkey N, Pilkhwal S, Chopra K. 6-Gingerol prevents cisplatin-induced acute renal failure in rats. Biofactors. 2006;26:189-200.
42. Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol. 2006;39:656-661.
43. Pratibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. Eur J Pharm. 2006;532:290-293.